Research
Hormonal
Patients who received the fluid-filled IGB were more likely to require urgent evaluation or treatment compared to those treated with the gas-filled IGB.
Clinicians should be aware of the higher likelihood of complications with the fluid-filled IGB.
StrongSupportsmedium confidence
Patients who received the fluid-filled IGB were more likely to require urgent evaluation or treatment.
Why this rating
Based on the retrospective cohort study design.
Source
Comparison of the Efficacy and Safety of the FDA-approved Intragastric Balloon Systems in a Clinical Setting
Eric Swei et al. · Journal of Clinical Gastroenterology · 2022
DOI 10.1097/mcg.0000000000001718
cohort · n=87Cited 9×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →